Covered recipient · General Payments record
PEDRO P MARTIN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$773.54
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $383.58 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $125.93 | 2 |
| Novo Nordisk AS | $72.23 | 3 |
| Phathom Pharmaceuticals, Inc. | $52.97 | 3 |
| Amgen Inc. | $39.15 | 2 |
| PFIZER INC. | $29.08 | 1 |
| Lilly USA, LLC | $24.97 | 1 |
| Corcept Therapeutics | $21.23 | 1 |
| GlaxoSmithKline, LLC. | $18.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $19.12 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117620574 | CMS |
| Amgen Inc. | $20.03 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117620576 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.81 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104313526 | CMS |
| AstraZeneca Pharmaceuticals LP | $109.12 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104416479 | CMS |
| Corcept Therapeutics | $21.23 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117743594 | CMS |
| GlaxoSmithKline, LLC. | $18.02 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116484659 | CMS |
| Lilly USA, LLC | $24.97 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135272106 | CMS |
| Novo Nordisk Inc | $22.53 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096672512 | CMS |
| Novo Nordisk Inc | $32.95 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096901117 | CMS |
| Novo Nordisk Inc | $16.75 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096599791 | CMS |
| PFIZER INC. | $29.08 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132019605 | CMS |
| Phathom Pharmaceuticals, Inc. | $21.76 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151093643 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.17 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151093645 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.04 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151093647 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.